Bill & Melinda Gates Medical Research Institute begins Phase 3 clinical trial of Tuberculosis vaccine
Cambridge: The Bill & Melinda Gates Medical Research Institute (Gates MRI) has announced that a Phase 3 clinical trial to assess the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidate is now underway, with first doses given in South Africa, where TB takes a heavy toll. “If shown to be well-tolerated and effective, M72/AS01E could […]